news FDA accepts regulatory submission for Lynparza in metastatic breast cancerBy Dr Zara Kassam (European Pharmaceutical Review)
news Janssen announces FDA approval of Stelara for plaque psoriasisBy Dr Zara Kassam (European Pharmaceutical Review)
news FDA grants breakthrough therapy designation to Tagrisso for NSCLCBy Dr Zara Kassam (European Pharmaceutical Review)
news FDA approves Verzenio for metastatic breast cancerBy Dr Zara Kassam (European Pharmaceutical Review)
news EC grants marketing authorisation of Dupixent for atopic dermatitisBy Dr Zara Kassam (European Pharmaceutical Review)
news UCB receives EU approval for paediatric anti-epileptic drugBy Dr Zara Kassam (European Pharmaceutical Review)
news FDA approves first biosimilar for the treatment of cancerBy Dr Zara Kassam (European Pharmaceutical Review)
news Merck joins forces to pioneer global oncology big data initiativeBy Dr Zara Kassam (European Pharmaceutical Review)
news FDA grants Breakthrough designation to Cemiplimab for CSCCBy Dr Zara Kassam (European Pharmaceutical Review)
news FDA approves Mylotarg for treatment of acute myeloid leukemiaBy Dr Zara Kassam (European Pharmaceutical Review)
news Pharma businesses failing to report data breachesBy Dr Zara Kassam (European Pharmaceutical Review)
Follow: